Savagner P, Miyashita T, Yamada Y
Laboratory of Developmental Biology and Anomalies, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland 20892.
J Biol Chem. 1990 Apr 25;265(12):6669-74.
Collagen II, the major component of cartilage, is synthesized primarily by chondrocytes and by certain cells in the eye. Previously, we have studied the regulatory regions of the collagen II gene by DNA transfection assays (Horton, W., Miyashita, T., Kohno, K., and Yamada, Y. (1987) Proc. Natl. Acad. Sci. U.S.A. 84, 8864-8868). These studies show that both the promoter and an enhancer sequence in the first intron are required for high transcriptional activity in chondrocytes. These elements do not show significant activity in cells which do not synthesize collagen II, such as in muscle cells and fibroblasts. In this report, we have constructed plasmids containing various deletions of the promoter of the collagen II gene, fused to a reporter gene for chloramphenicol acetyltransferase (CAT) and transfected them into both chick embryonic fibroblasts and HeLa cells. We have found that silencer elements in the collagen II promoter region reduce CAT activity 11-fold in fibroblasts, while not affecting the enhancer-mediated transcription in chondrocytes. Deletions in the promoter showed that most of the silencing activity was localized in two sites, between -360 and -460 base pairs and between -620 and -700 base pairs. Furthermore, a fragment containing these two sequences in a thymidine kinase promoter CAT construct reduced the activity of the promoter in an orientation independent fashion. Sequence analysis revealed that the two silencer regions are homologous and contain consensus motifs for silencer elements found in other genes. Gel retardation experiments showed that nuclear factors from HeLa cells bind specifically to a DNA fragment containing the silencer, whereas chondrocyte nuclear extracts did not show any activity. Thus, our study indicates that the expression of the collagen II gene is controlled by both negative and positive elements to ensure that the gene is only expressed in suitable cells.
胶原蛋白II是软骨的主要成分,主要由软骨细胞和眼睛中的某些细胞合成。此前,我们通过DNA转染试验研究了胶原蛋白II基因的调控区域(霍顿,W.,宫下,T., Kohno,K.,和山田,Y.(1987年)美国国家科学院院刊84,8864 - 8868)。这些研究表明,内含子1中的启动子和增强子序列对于软骨细胞中的高转录活性都是必需的。这些元件在不合成胶原蛋白II的细胞中,如肌肉细胞和成纤维细胞中,没有显著活性。在本报告中,我们构建了含有胶原蛋白II基因启动子各种缺失的质粒,将其与氯霉素乙酰转移酶(CAT)报告基因融合,并将它们转染到鸡胚成纤维细胞和HeLa细胞中。我们发现,胶原蛋白II启动子区域中的沉默元件在成纤维细胞中使CAT活性降低了11倍,而不影响软骨细胞中增强子介导的转录。启动子的缺失表明,大多数沉默活性定位于两个位点,在-360至-460碱基对之间以及-620至-700碱基对之间。此外,在胸苷激酶启动子CAT构建体中包含这两个序列的片段以方向独立的方式降低了启动子的活性。序列分析表明,这两个沉默区域是同源的,并且包含在其他基因中发现的沉默元件的共有基序。凝胶阻滞实验表明,HeLa细胞的核因子特异性结合含有沉默子的DNA片段,而软骨细胞核提取物没有显示任何活性。因此,我们的研究表明,胶原蛋白II基因的表达受负性和正性元件的控制,以确保该基因仅在合适的细胞中表达。